Orthocell Limited

ASX:OCC.AX

0.62 (AUD) • At close October 30, 2024
Bedrijfsnaam Orthocell Limited
Symbool OCC.AX
Munteenheid AUD
Prijs 0.62
Beurswaarde 130,619,740
Dividendpercentage 0%
52-weken bereik 0.345 - 0.765
Industrie Biotechnology
Sector Healthcare
CEO Mr. Paul Frederick Anderson
Website https://orthocell.com

An error occurred while fetching data.

Over Orthocell Limited

Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia. The company offers CelGro, a naturally derived collagen medical device for use in multiple indications to augment the surgical repair of bone, peripheral

Vergelijkbare Aandelen

Emyria Limited logo

Emyria Limited

EMD.AX

0.03 AUD

Microba Life Sciences Limited logo

Microba Life Sciences Limited

MAP.AX

0.18 AUD

MedAdvisor Limited logo

MedAdvisor Limited

MDR.AX

0.35 AUD

Antisense Therapeutics Limited logo

Antisense Therapeutics Limited

ANP.AX

0.058 AUD

Biotron Limited logo

Biotron Limited

BIT.AX

0.021 AUD

Micro-X Limited logo

Micro-X Limited

MX1.AX

0.068 AUD

Invion Limited logo

Invion Limited

IVX.AX

0.003 AUD

Doctor Care Anywhere Group PLC logo

Doctor Care Anywhere Group PLC

DOC.AX

0.071 AUD

CleanSpace Holdings Limited logo

CleanSpace Holdings Limited

CSX.AX

0.485 AUD

Financiële Gegevens

Cijfers zijn in miljoenen (AUD)

Cijfers zijn in miljoenen (AUD)